Date | Price Target | Rating | Analyst |
---|---|---|---|
7/29/2024 | $25.00 | Buy | Alliance Global Partners |
7/19/2024 | $22.00 | Buy | Canaccord Genuity |
10/9/2023 | $25.00 | Buy | H.C. Wainwright |
7/19/2023 | $30.00 | Buy | Canaccord Genuity |
Alliance Global Partners initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00
Canaccord Genuity resumed coverage of Cibus Global with a rating of Buy and set a new price target of $22.00
H.C. Wainwright initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00
Canaccord Genuity resumed coverage of Cibus Global with a rating of Buy and set a new price target of $30.00
8-K - Cibus, Inc. (0001705843) (Filer)
424B5 - Cibus, Inc. (0001705843) (Filer)
8-K - Cibus, Inc. (0001705843) (Filer)
10-Q - Cibus, Inc. (0001705843) (Filer)
8-K - Cibus, Inc. (0001705843) (Filer)
8-K - Cibus, Inc. (0001705843) (Filer)
424B5 - Cibus, Inc. (0001705843) (Filer)
8-K - Cibus, Inc. (0001705843) (Filer)
10-Q - Cibus, Inc. (0001705843) (Filer)
8-K - Cibus, Inc. (0001705843) (Filer)
SAN DIEGO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that it intends to offer shares of its Class A common stock in an underwritten public offering. Cibus also expects to grant to the underwriters of the offering a 45-day option to purchase up to an additional 15% of the shares of Class A common stock offered in the underwritten public offering on the same terms and conditions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offe
Initial data from Pod Shatter Reduction field trials show promising results The first gene edited trait to complete field trials in oilseed rape in the UK SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that it has completed initial field tests of its Pod Shatter Reduction (PSR) trait in the United Kingdom. The initial data from these trials support Cibus' continuing commercial development of its PSR trait in winter oilseed rape. These trials represent an important progression in the Company's commercial development with the
SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops plant traits to license to seed companies for royalties, today announced its participation in the following August investor events. Canaccord Genuity 44th Annual Growth Conference, Boston, MA – August 13-14, 2024: Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, and Peter Beetham, Co-Founder, President, and Chief Operating Officer will host a presentation beginning at 12:30 p.m. ET (9:30 a.m. PT) on August 14. Webcast link: https://wsw.com/webcast/canaccord98/cbus/2460579 Sidoti Micro Cap Conference, Virtual – August 14-15, 2024: Mr. Riggs and Mr.
Demonstrated continued momentum securing an agreement for its Herbicide Tolerance (HT) traits in Rice with a fourth customer in the second quarter with signing of agreement with Federacion Nacional de Arroceros ("FEDEARROZ"); builds on prior agreements with Loveland Products, Inc., a subsidiary of Nutrien, Ltd., in the United States and with Interoc S.A. in Latin America Rice platform is the Company's first entry into the major global grain crops with significant potential commercial opportunities Wheat platform operational, enables Cibus access into the largest global grain crop in planted acres Continued achievement of milestones in the development of its Advanced Trai
Early results of a novel weed management solution using two herbicides show promise. The first known use of stacked gene edited herbicide tolerant traits in an elite variety of rice to improve weed management. SAN DIEGO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that it has positive initial field trial results of a novel weed management solution for rice farmers. Initial results have shown that using two herbicides provided an excellent weed management system in rice. If ultimately successful, stacking gene edited herbicide tolerant (HT
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that the company will report second quarter 2024 financial results on Thursday, August 8, 2024. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Second Quarter 2024 Results Conference Call Event Date: Thursday, August 8, 2024 Time: 4:30 p.m. ET Participant Numbers: +1-800-343-5172 (U.S.), +1-203-518-9856 (International)The conference ID "CIBUS" or 2
Additional patents issued for 10 plant trait and editing families in the past two quarters. Strengthens Cibus' intellectual property portfolio in its Pod Shatter Reduction (PSR), Herbicide Tolerances (HTs), High Fiber Wheat and Improved Quality Alfalfa trait families. SAN DIEGO, June 26, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that it has expanded its intellectual property coverage for 10 gene editing and trait families. This intellectual property expansion over the last 6 months covers several areas including gene editing, productivity traits and
Nutrient Use Efficiency Traits are an Important Large Category of Traits that can Make Fertilizer Use More Efficient on a Global Basis The First Case of Cibus Using its Trait Machine Process for a Third Party Developed Trait SAN DIEGO, June 17, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. ("Cibus" or the "Company") (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced it has confirmed it has successfully made edits in Canola for its initial Nutrient Use Efficiency (NUE) trait. These newly edited plants will now be tested in controlled environments. If successful, Cibus expects this will mark a mi
SAN DIEGO, June 12, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced it has entered into securities purchase agreements with institutional, strategic and existing investors of the Company, as well as with the Company's CEO, Rory Riggs, for the purchase and sale of 1,298,040 shares of its Class A Common Stock, par value $0.0001 per share, and warrants to purchase up to an aggregate of 1,298,040 shares of Class A Common Stock, at a combined purchase price per share (and accompanying w
SAN DIEGO, June 05, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced its participation in the following June investor events. Stifel Cross Sector Insight Conference, Boston, MA - June 5, 2024: Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, will host a presentation beginning at 1:50 p.m. ET (10:50 a.m. PT). A live audio webcast of the presentation will be accessible through the link below: Webcast link: https://wsw.com/webcast/stifel89/cbus/2099832 Bank of America AgTech Conference, Virtual - June 6, 2024: Mr. Riggs and Peter Beetham, Co-Fo
4 - Cibus, Inc. (0001705843) (Issuer)
4 - Cibus, Inc. (0001705843) (Issuer)
4 - Cibus, Inc. (0001705843) (Issuer)
4 - Cibus, Inc. (0001705843) (Issuer)
4/A - Cibus, Inc. (0001705843) (Issuer)
4/A - Cibus, Inc. (0001705843) (Issuer)
4/A - Cibus, Inc. (0001705843) (Issuer)
4 - Cibus, Inc. (0001705843) (Issuer)
4 - Cibus, Inc. (0001705843) (Issuer)
4 - Cibus, Inc. (0001705843) (Issuer)
Canaccord Genuity analyst Austin Moeller assumes Cibus (NASDAQ:CBUS) with a Buy rating and announces Price Target of $22.
Strengthens Portfolio in Pod Shatter Reduction, Herbicide Tolerances, High Fiber Wheat, and Improved Quality Alfalfa; Covers Europe, Asia, Latin America, Canada, and the U.S.
On Wednesday, Cibus Inc (NASDAQ:CBUS) announced that it has expanded its intellectual property coverage for ten gene editing and trait families. Over the last six months, intellectual property expansion has covered several areas, including gene editing, productivity traits, and quality traits, like high-fiber wheat. This strengthens the company’s patent coverage in geographies including, but not limited to, Europe, Asia, Latin America, Canada, and the U.S. Cibus is focused on developing complex gene-edited traits in plants, such as Pod Shatter Reduction in Canola and Herbicide Tolerance in Rice. The company’s plant trait intellectual property is developed using its Rapid Trait De
Shares of Core & Main Inc (NYSE:CNM) fell sharply during Tuesday's session after the company reported mixed first-quarter financial results. Core & Main posted quarterly earnings of 49 cents per share, missing market expectations of 52 cents per share. The company's quarterly sales came in at $1.74 billion versus estimates of $1.72 billion, according to data from Benzinga Pro. Core & Main shares dipped 11.4% to $49.77 on Tuesday. Here are some other stocks moving in today’s mid-day session. Gainers MicroAlgo Inc (NASDAQ:MLGO) shares jumped 284% to 5.99 after the company announced that it will jointly establish a micro-consciousness quantum research center with WiMi. Sobr S
HC Wainwright & Co. analyst Amit Dayal reiterates Cibus (NASDAQ:CBUS) with a Buy and maintains $25 price target.
Cibus (NASDAQ:CBUS) reported quarterly losses of $(1.12) per share. This is a 79.49 percent increase over losses of $(5.46) per share from the same period last year. The company reported $545.000 thousand in sales this quarter. This is a 1.20K percent increase over sales of $42.000 thousand the same period last year.
Demonstrated continued momentum securing an agreement for its Herbicide Tolerance (HT) traits in Rice with a fourth customer in the second quarter with signing of agreement with Federacion Nacional de Arroceros ("FEDEARROZ"); builds on prior agreements with Loveland Products, Inc., a subsidiary of Nutrien, Ltd., in the United States and with Interoc S.A. in Latin America Rice platform is the Company's first entry into the major global grain crops with significant potential commercial opportunities Wheat platform operational, enables Cibus access into the largest global grain crop in planted acres Continued achievement of milestones in the development of its Advanced Trai
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that the company will report second quarter 2024 financial results on Thursday, August 8, 2024. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Second Quarter 2024 Results Conference Call Event Date: Thursday, August 8, 2024 Time: 4:30 p.m. ET Participant Numbers: +1-800-343-5172 (U.S.), +1-203-518-9856 (International)The conference ID "CIBUS" or 2
Important EU Parliament vote on gene editing continues global momentum for the approval of new genomic techniques (NGTs) as similar to conventional breeding Completed single cell regeneration platform for Wheat – with Canola & Rice, Cibus now has its semi-automated crop platform operational for 3 of the top 5 major crops Signed three agreements in Rice including with Loveland Products Inc., a subsidiary of Nutrien Ltd., and Interoc S.A., for Cibus' two proprietary Herbicide Tolerance traits (HT1 and HT3) Continued progress with customers toward commercializing Pod Shatter Reduction (PSR) trait in Canola Continues to demonstrate commercial-level trait performance following successful seas
SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report first quarter 2024 financial results on Thursday, May 9, 2024. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. First Quarter 2024 Results Conference Call Event Date: Thursday, May 9, 2024 Time: 4:30 p.m. ET Participant Numbers: +1-877-704-4453 (U.S.), +1-201-389-0920
SAN DIEGO, March 07, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report fourth quarter 2023 financial results on Thursday, March 21, 2024. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Fourth Quarter 2023 Results Conference Call Event Date: Thursday, March 21, 2024Time: 4:30 p.m. ETParticipant Numbers: +1-877-704-4453 (U.S.), +1-201-389-0920 (Internation
During the 2023 field season, Cibus completed extensive field trials for its three developed traits, PSR in canola and HT1 and HT3 in rice. Company also reports continued progress of Cibus' high-throughput soybean editing system and its two advanced traits for Sclerotinia resistance and HT2. Initial UK field trials for its PSR trait in WOSR are underway in conjunction with positive tailwinds in European regulatory progress; accelerating Cibus' PSR trait in the European market. Launched strategic realignment and cost savings initiatives to direct focus towards advancing late-stage activities, aligning with its primary commercial objectives. Management to host a conference call webcast Thu
SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a global leader in gene editing in agriculture and the development of productivity traits in plants, today announced that the Company will report third quarter 2023 financial results on Thursday, November 9, 2023. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Third Quarter 2023 Results Conference CallEvent Date: Thursday, November 9, 2023Time: 4:30 p.m. ETParticipant Numbers: +1-877-243-8548 (U.S.), +1-312-281-2974 (International)Event Link: https://investor.cibus.com/events For interested
Two gene editing pioneers closed merger to create a leading agricultural gene editing company with an expanded portfolio of patents, patents pending, and exclusive licenses to core technologies for gene editing of plants. Important greenhouse data continues to show promising results for Cibus' first disease resistance trait for Sclerotinia resistance. Begins commercialization process for its three developed traits with initial transfers to customers: pod shatter reduction in canola and HT1 and HT3 in rice. Opens first stand-alone high-throughput (gene editing) breeding facility for trait production to support the commercial launch of its first three developed traits across can
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report second quarter 2023 financial results on Thursday, August 10, 2023. Cibus' management team will host a conference call and audio webcast at 8:00 a.m. ET on that day to discuss the financial results and other company updates. A live audio webcast of the call, along with accompanying slides, will be available under "News & Events" in the Investor section of the Company's website, investor.cibus.com. An archived webcast will be available on the Company's website for 90 days a
Cibus Announces Election of New Board Member, Deepening Strategic Leadership and Experience SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a global leader in Gene Editing in agriculture and the development of Productivity Traits in plants that directly impact farming productivity and profitability announced that its Board of Directors has elected Jim Collins, former CEO of Corteva, to the Board. "Jim brings to Cibus immense knowledge and strategic vision on the direction of the future role and use of Gene Editing in agriculture," said Mark Finn, Chair of the Audit Committee. "Jim's experience leading one of the largest agricultural and seed companies will gi
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, announced today the appointment of Steve Berreth as General Counsel and Corporate Secretary for the corporation. Mr. Berreth was previously Vice President, General Counsel and Secretary for Syngenta Crop Protection LLC, the North American Subsidiary of Syngenta AG, one of the world's largest biotechnology agribusinesses and one of the largest crop protection chemical and seed businesses in the world. He was a member of the Syngenta global legal and compliance leadership teams and led the North American le